David Roth is interested in the molecular mechanisms underlying the development and function of the immune system, particularly regulatory mechanisms that maintain genomic stability during antigen receptor diversification, genetic lesions in this mechanism that lead to immunodeficiency, and aberrant V(D)J recombination events that lead to leukemias and lymphomas.